Nathan Richoz

9.4k total citations
14 papers, 444 citations indexed

About

Nathan Richoz is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Nathan Richoz has authored 14 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Nathan Richoz's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Phagocytosis and Immune Regulation (3 papers). Nathan Richoz is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Phagocytosis and Immune Regulation (3 papers). Nathan Richoz collaborates with scholars based in United Kingdom, United States and Portugal. Nathan Richoz's co-authors include Richard M. Siegel, Menna R. Clatworthy, Zewen Kelvin Tuong, Kevin W. Loudon, John R. Ferdinand, Kathleen R Bashant, Mariana J. Kaplan, M. Zaeem Cader, Arthur Kaser and Tomas Castro‐Dopico and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Immunity.

In The Last Decade

Nathan Richoz

13 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Richoz United Kingdom 9 254 161 88 71 47 14 444
Jinlin Miao China 14 218 0.9× 176 1.1× 89 1.0× 94 1.3× 36 0.8× 36 473
Hong‐Tai Tzeng Taiwan 13 186 0.7× 181 1.1× 119 1.4× 67 0.9× 53 1.1× 21 451
Dorian LaTocha United States 13 261 1.0× 238 1.5× 87 1.0× 104 1.5× 34 0.7× 19 663
Manuela Kolster Germany 6 383 1.5× 80 0.5× 90 1.0× 48 0.7× 26 0.6× 9 555
Shankar Revu United States 9 234 0.9× 86 0.5× 82 0.9× 88 1.2× 30 0.6× 14 404
María Jesús Domínguez‐Luis Spain 10 167 0.7× 82 0.5× 144 1.6× 122 1.7× 49 1.0× 13 437
Huaxi Xu China 10 350 1.4× 141 0.9× 86 1.0× 92 1.3× 58 1.2× 12 613
Gray Roberge United States 4 293 1.2× 182 1.1× 45 0.5× 23 0.3× 31 0.7× 5 484
Xiang-Pei Li China 6 209 0.8× 82 0.5× 55 0.6× 72 1.0× 34 0.7× 6 372
Fengxia He China 11 128 0.5× 148 0.9× 53 0.6× 24 0.3× 68 1.4× 19 346

Countries citing papers authored by Nathan Richoz

Since Specialization
Citations

This map shows the geographic impact of Nathan Richoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Richoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Richoz more than expected).

Fields of papers citing papers by Nathan Richoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Richoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Richoz. The network helps show where Nathan Richoz may publish in the future.

Co-authorship network of co-authors of Nathan Richoz

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Richoz. A scholar is included among the top collaborators of Nathan Richoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Richoz. Nathan Richoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lee, Colin Y.C., Isaac Dean, Nathan Richoz, et al.. (2025). In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade. Cancer Immunology Research. 13(9). 1453–1470.
2.
Richoz, Nathan, Zewen Kelvin Tuong, Georgina Bowyer, et al.. (2025). Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge. Nature Immunology. 26(2). 215–229. 1 indexed citations
3.
Hasegawa, Tetsuo, Colin Y.C. Lee, Andrew Hotchen, et al.. (2024). Macrophages and nociceptor neurons form a sentinel unit around fenestrated capillaries to defend the synovium from circulating immune challenge. Nature Immunology. 25(12). 2270–2283. 8 indexed citations
4.
Lee, Colin Y.C., Nathan Richoz, Isaac Dean, et al.. (2024). Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. Nature Communications. 15(1). 682–682. 30 indexed citations
5.
Stewart, Andrew P., Kevin W. Loudon, Matthew Routledge, et al.. (2024). Neutrophil extracellular traps protect the kidney from ascending infection and are required for a positive leukocyte dipstick test. Science Translational Medicine. 16(766). eadh5090–eadh5090. 4 indexed citations
6.
Richoz, Nathan, Zewen Kelvin Tuong, Kevin W. Loudon, et al.. (2022). Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis. JCI Insight. 7(21). 40 indexed citations
7.
Riding, Alexandra, Kevin W. Loudon, Andrew Guo, et al.. (2022). Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence. iScience. 25(7). 104660–104660. 10 indexed citations
8.
Geiger, Sarah S., Javier Traba, Nathan Richoz, et al.. (2021). Feeding-induced resistance to acute lethal sepsis is dependent on hepatic BMAL1 and FXR signalling. Nature Communications. 12(1). 2745–2745. 23 indexed citations
9.
Tuong, Zewen Kelvin, Kevin W. Loudon, Brendan Berry, et al.. (2021). Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Reports. 37(12). 110132–110132. 68 indexed citations
10.
Jing, Chenzhi, Tomas Castro‐Dopico, Nathan Richoz, et al.. (2020). Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proceedings of the National Academy of Sciences. 117(26). 15160–15171. 153 indexed citations
11.
Schwartz, Daniella M., Taylor K. Farley, Nathan Richoz, et al.. (2019). Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology. Immunity. 50(1). 106–120.e10. 58 indexed citations
12.
Richoz, Nathan, Taylor K. Farley, Samantha A. Chalmers, et al.. (2017). Expression of the TNF-family cytokine TL1A (TNFSF15) by renal CX3CR1+ resident mononuclear phagocytic cells and role of TL1A in autoimmune nephritis. The Journal of Immunology. 198(Supplement_1). 63.11–63.11. 1 indexed citations
13.
Farley, Taylor K., Nathan Richoz, Sarah Lamberth, et al.. (2017). The relationship between the cytokines TNF and TL1A in rheumatoid arthritis. The Journal of Immunology. 198(Supplement_1). 201.1–201.1. 1 indexed citations
14.
Cruz, Anthony, Madhu Ramaswamy, Christopher A. Klebanoff, et al.. (2016). Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nature Communications. 7(1). 13895–13895. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026